Thousands of Investors Now Petition To Stop FINRA’s Absolute Immunity

Thousands of investors are now petitioning to stop FINRA’s absolute immunity as concerns resurface on social media.

The FINRA-MMTLP blue sheet motion was dismissed in June by a judge in the Supreme Court of New York City for allegations deemed as “speculative and conclusory”.

The self-regulatory body claimed immunity and refused to provide retail investors with the blue sheets that shed light on the trading activity and fraud that occurred in ticker symbol MMTLP prior to the U3 halt and delisting.

FINRA stated that the petitioner’s request is ‘overbroad and unduly burdensome’, being one of the few claims to deny MMTLP investors the blue sheets.

They also state that blue sheet data may reveal the confidential trading approach of firms and their customers, and includes personal, financial, and identifying information for individual and other investors.

Investors started a petition at the time of the events and has now resurfaced with nearly 1,900 signatures to end FINRA’s immunity.

Investors have shared their concerns about the self-regulatory body having too much concentrated power with no oversight.

Today, senator inquiries have grown regarding the MMTLP scandal.

“In light of FINRA’s inability to protect retail investors, as stated in their mission statement, and amidst of the concerns of illegal naked shorting, spoofing and market manipulation present in the stock market, I propose the SEC and Congress strip FINRA’s SRO status and its Absolute Immunity protection.

A regulatory body such as FINRA (or any public, private or self-regulated body for that matter) should not be able to shield itself from any form of litigation on the basis of absolute immunity.

The judicial system works only if everybody and every body has equal participation,” sates the petition.

Also Read: Member of Congress Orders MMTLP Share Count in New Letter

Market News Published Daily 📰

Market News Today - Thousands of Investors Now Petition To Stop FINRA's Absolute Immunity.
Market News Today – Thousands of Investors Now Petition To Stop FINRA’s Absolute Immunity.

Don’t forget to opt-in for push notifications so you don’t miss a single article!

Also, thank you to all of our blog sponsors. This year we’ve been able to increase push notifications slots making it more convenient than ever for new readers to receive their daily market news and updates.

You can also follow me on TwitterInstagramFacebook, or LinkedIn for daily news and updates on your favorite stories.


Become a Sponsor for only $1/mo.

  • Gain access to EXCLUSIVE FrankNez articles you won’t find here.
  • Become part of a private and safe Discord community, just for retail investors.
  • Get drawn at the end of the year for holiday giveaways.


4 Comments

  1. Norman Sanders

    FINRA “in my opinion” does not serve the interests of investors as it is supposed to. The SEC turns its back on investors letting FINRA hinder by hiding things from investors. They do not report everything that could be useful to investors. Why would FINRA be given absolute immunity? Get rid of FINRA and its ridiculous absolute immunity. Who gave FINRA absolute immunity and why would they do such a thing? Was it the SEC, which is a government agency, while FINRA is an independent organization empowered by Congress to make sure investors receive fair treatment among other things? This is all “in my opinion”. What is your opinion?

  2. mrcomp11

    Finra, as a government agency MUST have protections for both parties, they must show transparency and should not be immune to scrutiny. SHOW YOUR BOOKS!

    • Norman Sanders

      FINRA is not a Government Agency. FINRA is a private organization, empowered by Congress, that is supposed to serve the interests of the people among other duties that it is assigned. I agree with you though: SHOW YOUR BOOKS FINRA. Who told you to hide things from the public you are serving? The FED is also not a government agency.

  3. Frank Nez

    Leave your thoughts below.

© 2024 Franknez.com

Theme by Anders NorenUp ↑